Guest guest Posted March 27, 2002 Report Share Posted March 27, 2002 West Wing is doing reruns tonight (we get last week's program this week) so I'll have time to update the list on some interesting research conclusions related to Lytico-Bodig. L/B is one of the Parkinsons Plus diseases and considered by some to be the worst. Lytico-Bodig is a unique disease found almost entirely among Chamorros on Guam. The disease seemed to rise especially among Chamorros born on Guam during and after WWII. Because certain forms of the disease had aspects that were similar to Parkinsons, Guam has attracted a number of famous neuro researchers. The thinking was the disease was uniquely found among the indigenous population. It also seemed to be localized to certain parts of the island. In the 50's, 60's and 70's this meant that the disease could be studied using demographic techniques. The thought was that sharp demographic work would help determine whether the disease had an environmental component or whether the disease had a genetic component. It was also hoped that simple extrapolation would lead to new insights about Parkinsons. One of the best known of the demographic researchers was Steele who had become known before he came to Guam as one of the two people who first described / discovered PSP. Dr. Steele has spent many years in demographic work with L/B. So far nothing in his data has made sense. A year or so ago I spent a couple of hours talking with Dr. Steele about the life of a researcher and the lines of inquiry he was continuing to study. A most interesting conversation. More recently the University of Guam and some famous researchers from the University of California at San Diego got together to study Lytico-Bodig using the new genetic research techniques, looking at the genome and the genes and chromosomes. Again it was an attempt to take the human mind where it had never gone before. These researchers have been working on their study for several years. I just spent an hour with the project manager of the study. Their work is not yet published but she indicates that despite all their effort, no genetic markers of any kind have been identified. Again the disease baffles the best minds. Most recently - so recently I don't have the reference - a reputable neurological journal has published an article, apparently by people from Hawaii, indicating that Lytico-Bodig is caused by eating fruit bats (locally called fanihi) that have eaten certain kinds of palm nuts that contain neuro-toxins. Again this is interesting. First of all, although they are currently almost extinct on Guam, fruit bats are considered a great delicacy and occasionally you will find a boiled fruit bat, wings, fur, ticks and all, floating in coconut milk at a village fiesta. (No I have not tasted them although I have been known to eat almost anything. I prefer pulling pork from the whole roast pigs). Supposedly the bats pick up the toxin in their proteins and that attacks the brains of those eating the bats. The fact that fruit bats are now rare on Guam provides a convenient explanation for why Lytico-Bodig is dying out on Guam. Interestingly also, the nuts that are thought to be the cause of the problem are the same kinds of nuts initially thought by some to be the cause of the disease in some early theories. In these theories, during the most difficult times in WWII, people would make a kind of flour from the nuts. People were supposed to rinse the nuts in water to remove the toxins. However during the war, so this theory went, some weren't able to rinse the nuts well enough. However this version of the nut theory never held up in the face of good demographic investigation. I have not located the article so I can't really critique the statements made on local radio and television. However the new theory apparently fails also. Fruit bats are eaten all over the islands of the Pacific. The question would be why Lytico-Bodig has only appeared on Guam. I don't know if this theory will bite the dust (or sea water) but it will be interesting to follow up on what is actually being proposed. Many tasty fruit bats to you all. Peg and Jim from Guam ******************************** *** Peg & Jim *** # 29 Cruz Heights *** Ipan-Talofofo, Guam 96930-4736 *** USA *** *** Note: Guam is 15 hours ahead of *** Eastern Standard Time (EST). *** 14 ahead of EDT. ******************************** Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 27, 2002 Report Share Posted March 27, 2002 Very interesting report Jim. Thanks! Here are some recent articles that discuss Lytico-Bodig (aka Parkinson-dementia complex of Guam). Note the 3rd report is about a strange cluster of PSP-like disorders on the island of Guadeloupe. Hugs, Pam ---- Neurology 2002 Jan 8;58(1):90-7 Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Galasko D, Salmon DP, Craig UK, Thal LJ, Schellenberg G, Wiederholt W. Department of Neurosciences (Drs. Galasko, Salmon, and Thal), University of California, San Diego. BACKGROUND: In the 1950s, high-incidence ALS and Parkinson-dementia complex (PDC) were identified among Chamorros, the native inhabitants of Guam. Brains of patients with these syndromes showed widespread neurofibrillary tangles. Although ALS and PDC were reported to have dramatically declined in the 1980s, new cases are still encountered. Late-life dementia has received little study among Chamorros. METHODS: From 1997 to 2000, the authors evaluated newly referred and previously identified patients. They screened first-degree relatives of previous registries, and subjects aged 60 or older. Subjects who scored below a cognitive test cutoff or had symptoms or signs consistent with parkinsonism or ALS underwent psychometric testing, assessment by a neurologist, and laboratory studies as appropriate. Consensus diagnoses were made. RESULTS: The authors identified 194 Chamorros with ALS (n = 10), PD (n = 11), PDC (n = 90), or late-life dementia (n = 83). Mean ages at onset were 55 for ALS, 68 for PDC, 63 for PD, and 74 for dementia. Late-life dementia was more common in women, and met criteria for probable or possible AD. The APOE-epsilon4 allele frequency was uniformly low regardless of neurologic diagnosis. CONCLUSIONS: The rapid decline of high-incidence ALS on Guam over the past 40 years suggests the contribution of a modifiable environmental factor. PDC remains relatively common, with an unchanged clinical picture apart from later age at onset. Dementia among elderly Chamorros (termed " na dementia " ) resembles AD. Autopsy studies will clarify whether this dementia is related to AD pathology or represents a late-life neurofibrillary tangle syndrome more closely allied to PDC. PMID: 11781411 [PubMed - in process] ---- Neurology 2002 Mar 12;58(5):765-73 ALS and PDC of Guam: Forty-year follow-up. Plato CC, Galasko D, Garruto RM, Plato M, Gamst A, Craig UK, JM, Wiederholt W. BACKGROUND: It was noticed in the mid-1950s that the incidence of ALS and parkinsonism--dementia complex (PDC) were much higher on Guam than anywhere else in the world. In 1958, a registry of patients and controls was established to ascertain the familial and genetic aspects of these diseases. Patients and individually matched controls and their relatives were registered from 1958 to 1963. The registry was updated and analyzed in 1998 through 1999. OBJECTIVE: To ascertain whether first-degree relatives of patients had a higher risk for developing ALS or PDC than relatives of controls. Methods: During the period of 1958 to 1963, 126 new patients and 126 individually matched controls and their respective first-degree relatives and spouses were evaluated neurologically and registered. Forty years later, the number of new cases among the patient and control relatives were compared to an expected number of new cases based on the age- and sex-specific incidence of ALS and PDC in the population at large. RESULTS: From 1958 to 1999, there were 102 new ALS or PDC cases among relatives of patients and 33 among relatives of controls. These values were compared with the derived expected values. There were more observed than expected new cases among patients' relatives, and less observed cases than expected among the controls' relatives. CONCLUSIONS: Relatives of patients with ALS or PDC have significantly higher risks for developing the disease than the Guamanian population, whereas relatives of controls have significantly lower risks. PMID: 11889241 [PubMed - in process] ---- Brain 2002 Apr;125(Pt 4):801-811 Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, S, Lannuzel A, Brice A, Tolosa E, Delacourte A, Duyckaerts C. Neurologie, Centre Hospitalier Universitaire de la Guadeloupe, Pointe a Pitre, French West Indies, Laboratoire INSERM U 422, Lille, INSERM U 289 and. Laboratoire de Neuropathologie, CHU Pitie-Salpetriere, Paris, France, Hospital Clinici Provincial de Barcelona, Spain and. Reta Lila Weston Institute of Neurological Studies, Royal Free and University College London Medical School, London, UK. An unusually high frequency of atypical Parkinson syndrome has been delineated over the last 5 years in the French West Indies. Postural instability with early falls, prominent frontal lobe dysfunction and pseudo-bulbar palsy were common and three-quarters of the patients were L-dopa unresponsive. One-third of all patients seen had probable progressive supranuclear palsy (PSP). This new focus of atypical parkinsonism is reminiscent of the one described in Guam and may be linked to exposure to tropical plants containing mitochondrial complex I inhibitors (quinolines, acetogenins, rotenoids). Two hundred and twenty consecutive patients with Parkinson's syndrome seen by the neurology service at Pointe a Pitre, Guadeloupe University Hospital were studied. Currently accepted operational clinical criteria for Parkinson's syndromes were applied. The pathological findings of three patients who came to autopsy are reported. Fifty-eight patients had probable PSP, 96 had undetermined parkinsonism and 50 had Parkinson's disease, 15 had amyotrophic lateral sclerosis with parkinsonism and one had probable multiple system atrophy. All three PSP patients in whom post-mortem study was performed had early postural instability, gaze palsy and parkinsonian symptoms, followed by a frontolimbic dementia and corticobulbar signs. Neuropathological examination showed an accumulation of tau proteins, predominating in the midbrain. There was an exceptionally large accumulation of neuropil threads in Case 1. Biochemical studies detected a major doublet of pathological tau at 64 and 69 kDa in brain tissue homogenates. All cases were homozygous for the H1 tau haplotype, but no mutation of the tau gene was observed. Clinical, neuropathological and biochemical features were compatible with the diagnosis of PSP, although some unusual pathological features were noted in Case 1. A cluster of cases presenting with atypical parkinsonism is reported. Guadeloupean parkinsonism may prove to be a tauopathy identical or closely related to PSP. PMID: 11912113 [PubMed - as supplied by publisher] ______________________________________________________________________ File your taxes online! http://taxes.yahoo.ca Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.